Guideline for Prevention of Intravascular-Device–Related Infections

Infection Control

Volumn 17, Issue 7, 1996, Pages 438-473

  Pearson, Michele L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; INSTRUMENTATION; METHODOLOGY; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; RISK FACTOR;

CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CROSS INFECTION; HUMANS; INFECTION CONTROL; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 0030183205     PISSN: 01959417     EISSN: 23279451     Source Type: Journal    
DOI: 10.1017/S019594170000686X     Document Type: Article

References (435)

1. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164–167.
2. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9–16.
3. Haley RW, Schaberg DR, Von Allmen SD, McGowan JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980;141:248–257.
4. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
5. Arnow PM, Quimosing EM, Brech M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778–784.
6. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston, MA: Little, Brown and Co; 1992.
7. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991;91(suppl 3B):185S-191S.
8. Gantz NM, Presswood GM, Goldbert R, Doern G. Effects of dressing type and change interval on intravenous therapy complication rates. Diagn Microbiol Infect Dis 1984;2:325–332.
9. Ena J, Cercenado E, Martinez D, Bouza E. Cross-sectional epidemiology of phlebitis and catheter-related infections. Infect Control Hosp Epidemiol 1992;13:15–20.
10. Craven DE, Lichtenberg A, Kunches LM, et al. A randomized study comparing a transparent polyurethane dressing to a dry gauze dressing for peripheral intravenous catheter sites. Am J Infect Control 1985;6:361–366.
11. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983;118:839–851.
12. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991;114:845–854.
13. Hoffmann KK, Western SA, Kaiser DL, Wenzel RP, Groschel DH. Bacterial colonization and phlebitis-associated risk with transparent polyurethane film for peripheral intravenous site dressings. Am J Infect Control 1988;16:101–106.
14. Smallman L, Burdon DW, Alexander-Williams J. The effect of skin preparation and care on the incidence of superficial thrombophlebitis. Br J Surg 1980;67:861–862.
15. Collin J, Collin C, Constable FL, Johnston ID. Infusion thrombophlebitis and infection with various cannulas. Lancet 1975;2:150–153.
16. Larson E, Hargiss C. A decentralized approach to maintenance of intravenous therapy. Am J Infect Control 1984;12:177–186.
17. Gardner RM, Schwartz R, Wong HC, Burke JP. Percutaneous indwelling radial-artery catheters for monitoring cardiovascular function. Prospective study of the risk of thrombosis and infection. N Engl J Med 1974;290:1227–1231.
18. Samsoondar W, Freeman JB, Coultish I, Oxley C. Colonization of intravascular catheters in an intensive care unit. Am J Surg 1985;149:730–732.
19. Raad I, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 1993;23:17–26.
20. Band JD, Maki DG. Infections caused by arterial catheters used for hemodynamic monitoring. Am J Med 1979;67:735–741.
21. Thomas F, Burke JP, Parker J, et al. The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med 1983;11:807–812.
22. Maki DG, McCormick RD, Uman SJ, Wirtanen GW. Septic endarteritis due to intra-arterial catheters for cancer
23. chemotherapy. Cancer 1979;44:1228–1240.
24. Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med 1995;123:841–844.
25. Maki DG. Reactions associated with midline catheters for intravenous access. Ann Intern Med 1995;123:884–886.
26. Fontaine PJ. Performance of a new softening expanding midline catheter in home intravenous therapy patients. J Intraven Nurs 1991;14:91–99.
27. Rogan DH. Allergic-type reaction to a Landmark catheter. J Intraven Nurs 1993;16:118.
28. Briars G. Adverse reactions to elastomeric intravenous catheters in adolescents with cystic fibrosis. Lancet 1993;342:118.
29. Blum DY. Untoward events associated with use of midterm IV devices. J Intraven Nurs 1995;18:116–119.
30. Harwood IR, Greene LM, Kozakowski-Koch JA, Rasor JS. New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatr Pulmonol 1992;12:233–239.
31. Weeks-Lozano H. Clinical evaluation of Per-Q-Cath for both pediatric and adult home infusion therapy. J Intraven Nurs 1991;14:249–256.
32. Lee RB, Buckner M, Sharp KW. Do multi-lumen catheters increase central venous catheter sepsis compared to single-lumen catheters? J Trauma 1988;28:1472–1475.
33. Pemberton LB, Lyman B, Lander V, Covinsky J. Sepsis from triple- vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg 1986;121:591–594.
34. Yeung C, May J, Hughes R. Infection rate for single-lumen vs triple-lumen subclavian catheters. Infect Control Hosp Epidemiol 1988;9:154–158.
35. Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med 1988;84:667–672.
36. McCarthy MC, Shives JK, Robison RJ, Broadie TA. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. J Parenter Enteral Nutr 1987;11:259–262.
37. Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Enteral Nutr 1992;16:403–407.
38. Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J. Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 1992;93:277–282.
39. Prager RL, Silva J. Colonization of central venous catheters. South Med J 1984;77:458–461.
40. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987;147:873–877.
41. Collignon PJ, Soni N, Pearson IY, Woods WP, Munro R, Sorrell TC. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol 1986;24:532–535.
42. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990;28:2520–2525.
43. Snydman DR, Gorbea HF, Pober BR, Majka JA, Murray SA, Perry SK. Predictive value of surveillance skin cultures in total parenteral nutrition. Lancet 1982;2:1185–1188.
44. Gil RT, Kruse JA, Thill-Baharozian MC, Carlson RW. Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population. Arch Intern Med 1989;149:1139–1143.
45. Sitzmann JV, Townsend TR, Siler MC, Bartlett JG. Septic and technical complications of central venous catheterization: a prospective study of 200 consecutive patients. Ann Surg 1985;202:766–770.
46. Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989;159:310–319.
47. Armstrong CW, Mayhall CG, Miller KB, et al. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986;154:808–816.
48. Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic impregnated vascular catheters. J Infect Dis 1993;167:920–924.
49. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91(suppl 3B):197S-205S.
50. Rello J, Coll P, Net A, Prats G. Infection of pulmonary artery catheters. Epidemiologic characteristics and multivariate analysis of risk factors. Chest 1993;103:132–136.
51. Singh S, Nelson N, Acosta I, Check FE, Puri VK. Catheter colonization and bacteremia with pulmonary and arterial catheters. Crit Care Med 1982;10:736–739.
52. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1992;22:1729–1737.
53. Pinilla JC, Ross DF, Martin T, Crump H. Study of the incidence of intravascular catheter infection and associated septicemia in critically ill patients. Crit Care Med 1983;11:21–25.
54. Senagore A, Waller JD, Bonnell BW, Bursch LR, Scholten DJ. Pulmonary artery catheterization: a prospective study of internal jugular and subclavian approaches. Crit Care Med 1987;15:35–37.
55. Solomon SL, Alexander H, Eley JW, et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis J 1986;5:680–685.
56. Maki DG, Hassemer CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med 1981;70:733–738.
57. Phillips I, Eykyn S, Curtis MA, Snell JJ. Pseudomonas cepacia (multivorans) septicemia in an intensive care unit. Lancet 1971;1:375–377.
58. Gahrn-Hansen B, Alstrup P, Dessau R et al. Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect 1988;12:1–6.
59. Villarino ME, Jarvis WR, O'Hara C, Bresnahan J, Clark N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989;27:2433–2436.
60. Hekker TA, van Overhagen W, Schneider AJ. Pressure transducers: an overlooked source of sepsis in the intensive care unit. Intensive Care Med 1990;16:511–512.
61. Mermel LA, Maki DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: signs of the times. Infect Control Hosp Epidemiol 1989;10:47–53.
62. Thomas A, Lalitha MK, Jesudason MV, John S. Transducer related Enterobacter cloacae sepsis in post-operative cardiothoracic patients. J Hosp Infect 1993;25:211–214.
63. Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest 1976;69:338–344.
64. Weinstein RA, Stamm WE, Kramer L, Corey L. Pressure monitoring devices: overlooked source of nosocomial infection. JAMA 1976;236:936–938.
65. Buxton AE, Anderson RL, Klimek J, Quintiliani R. Failure of disposable domes to prevent septicemia acquired from contaminated pressure transducers. Chest 1978;74:508–513.
66. Donowitz LG, Marsik FJ, Hoyt JW, Wenzel RP. Serratia marcescens bacteremia from contaminated pressure transducers. JAMA 1979;242:1749–1751.
67. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products, IV: growth of microbial pathogens in fluids for intravenous infection. J Infect Dis 1975;131:267–272.
68. Beck-Sagué CM, Jarvis WR. Epidemic bloodstream infections associated with pressure transducers: a persistent problem. Infect Control Hosp Epidemiol 1989;10:54–59.
69. Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA 1981;246:1571–1574.
70. Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia-an outbreak caused by Flavobacterium species. N Engl J Med 1975;292:1099–1102.
71. Shinozaki T, Deane RS, Mazuzan JE, Hamel AJ, Hazelton D. Bacterial contamination of arterial lines. JAMA 1983;249:223–225.
72. Ducharme FM, Gauthier M, Lacroix J, Lafleur L. Incidence of infection related to arterial catheterization in children: a prospective study. Crit Care Med 1988;16:272–276.
73. Luskin RL, Weinstein RA, Nathan C, Chamberlin WH, Kabins SA. Extended use of disposable pressure transducers. A bacteriologic evaluation. JAMA 1986;255:916–920.
74. O'Malley MK, Rhame FS, Cerra FB, MCComb RC. Value of routine pressure monitoring system changes after 72 hours of use. Crit Care Med 1994;22:1424–1430.
75. Ryder MA. Peripheral access options. Surg Oncol Clin N Am 1995;4:395–427.
76. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe cost-effective alternative for long-term venous access. Arch Intern Med 1993;153:1791–1796.
77. Noble WC. Skin microbiology: coming of age. J Med Microbiol 1984;17:1–12.
78. Roth RR, James WD. Microbial ecology of the skin. Ann Rev Microbiol 1988;42:441–446.
79. Lam S, Scannell R, Roessler D, Smith MA. Peripherally inserted central venous catheters in an acute-care hospital. Arch Intern Med 1994;154:1833–1837.
80. Loughran SC, Borzatta M. Peripherally inserted central catheters: a report of 2,506 catheter days. J Parenter Enteral Nutr 1995;19:133–136.
81. Abi-Nader JA. Peripherally inserted central venous catheters in critical care patients. Heart Lung 1993;22:428–434.
82. Merrell SW, Peatross BG, Grossman MD, Sullivan JJ, Harker WG. Peripherally inserted central venous catheters. Low-risk alternatives for ongoing vascular access. West J Med 1994;160:25–30.
83. Goodwin ML, Carlson I. The peripherally inserted central catheter. A retrospective look at three years of insertions. J Intraven Nurs 1993;16:92–103.
84. Cardella JF, Fox PS, Lawler JB. Interventional radiologic placement of peripherally inserted central catheters. J Vasc Interv Radiol 1993;4:653–660.
85. Andrews JC, Marx MV, Williams DM, Sproat I, Walker- Andrews SC. The upper arm approach for placement of peripherally inserted central catheters for protracted venous access. Am J Roentgenol 1992;158:427–429.
86. James L, Bledsoe L, Hardaway LC. A retrospective look at tip location and complications of peripherally inserted central venous lines. J Intraven Nurs 1993;16:104–109.
87. Abraham JL, Mullen JL. A prospective study of prolonged central venous access in leukemia. JAMA 1982;248:2868–2873.
88. Pessa ME, Howard RJ. Complications of Hickman-Broviac catheters. Surg Gynecol Obstet 1985;161:257–260.
89. Rannem T, Ladefoged K, Tvede M, Lorentzen JE, Jarnum S. Catheter-related septicemia in patients receiving home parenteral nutrition. Scand J Gastroenterol 1986;21:455–460.
90. Darbyshire PJ, Weightman NC, Speller DC. Problems associated with indwelling central venous catheters. Arch Dis Child 1985;60:129–134.
91. Shulman RJ, Smith EO, Rahman S, Gardner P, Reed T, Mahoney D. Single- vs double-lumen central venous catheters in pediatric oncology patients. Am J Dis Child 1988;142:893–895.
92. Shapiro ED, Wald ER, Nelson KA, Spiegelman KN. Broviac catheter-related bacteremia in oncology patients. Am J Dis Child 1982;136:679–681.
93. Weightman NC, Simpson EM, Speller DC, Mott MG, Oakhill A. Bacteremia related to indwelling central venous catheters: prevention, diagnosis, and treatment. Eur J Clin Microbiol Infect Dis 1988;7:125–129.
94. Schuman ES, Winters V, Gross GF, Hayes JF. Management of Hickman catheter sepsis. Am J Surg 1985;149:627–628.
95. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine 1984;63:189–200.
96. Andrivet P, Bacquer A, Ngoc CV, et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 1994;18:199–206.
97. Howell PB, Walter PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995;75:1367–1375.
98. McDowell HP, Hart CA, Martin J. Implantable subcutaneous venous catheters. Arch Dis Child 1986;61:1037–1038.
99. Brickner H, Saeter G. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer 1986;57:1124–1129.
100. Wurzel CL, Halom K, Feldman JG, Rubin LG. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536–540.
101. Pegues D, Axelrod P McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156–162.
102. Gyves J, Ensminger W, Niederhuber J, et al. A totally-implanted injection port system for blood sampling and chemotherapy administration. JAMA 1984;251:2538–2541.
103. Lokich JJ, Bothe AJ, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol 1985;3:710–717.
104. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Complications from long-term indwelling central venous catheters in hematologic malignancy patients with special reference to infection. Cancer 1989;64:1747–1752.
105. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus total implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989;25:939–944.
106. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168–1174.
107. Khoury MD, Lloyd LR, Burrows J, Berg R, Yap J. A totally implanted venous access system for the delivery of chemotherapy. Cancer 1985;56:1231–1234.
108. van der Pijl H, Frissen PH. Experience with a totally implantable venous access device (Port-A-Cath) in patients with AIDS. AIDS 1992;6:709–713.
109. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infection in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91(suppl 3B):86S-89S.
110. Stillman RI, Wenzel RP, Donowitz LC. Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens. Am J Infect Control 1987;8:108–112.
111. Morrison AJ Jr., Freer CV, Searcy MA, Landry SM, Wenzel RP Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Am J Infect Control 1986;7:550–553.
112. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72S-75S.
113. Dougherty SH. Pathobiology of infection in prosthetic devices. Rev Infect Dis 1988;10:1102–1117.
114. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990;323:301–308.
115. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(suppl A):19–24.
116. Dugdal DC, Ramsey PG. Staphylococcus aureus bacteremia patients with Hickman catheters. Am J Med 1990;89:137–141.
117. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984;144:541–545.
118. Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992;11:675–682.
119. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989–1993. MMWR 1993;42:597–599.
120. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195–200.
121. Morris JG Jr., Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.
122. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148–1153.
123. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993–1000.
124. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750–755.
125. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700–705.
126. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363–1367.
127. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76–79.
128. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280–1285.
129. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resis-tant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.
130. Livornese LL Jr., Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.
131. Moellering RCJ. Enterococcal infections in patients treated with moxalactam. Rev Infect Dis 1982;4(suppl):708S-711S.
132. Yu VL. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med 1981;94:784–785.
133. Feliciano DV, Gentry LO, Bitondo CG, et al. Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus. Am J Surg 1986;152:674–681.
134. Pallares R, Dick R, Wenzel RP, Adams JR, Nettleman MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978–1992). Infect Control Hosp Epidemiol 1993;14:376–382.
135. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA 1993;269:598–602.
136. Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 19801990. J Infect Dis 1993;167:1247–1251.
137. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994;32:975–980.
138. Pfaller MA, Cabezudo I, Hollis R, Huston B, Wenzel RP. The use of biotyping and DNA fingerprinting in typing Candida albicans from hospitalized patients. Diagn Microbiol Infect Dis 1990;13:481–489.
139. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990;28:2733–2738.
140. Moro ML, Maffei C, Manso E, Morace G, Polonelli L, Biavasco F. Nosocomial outbreaks of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol 1990;11:27–35.
141. Sherertz RJ, Gledhill KS, Hampton KD, et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr 1992;120:455–461.
142. Weems JJ, Chamberland ME, Ward J, Willy M, Padnye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987;1925:1029–1032.
143. Phelps M, Ayliffe GA, Babb JR. An outbreak of candidiasis in a special care baby unit: the use of a resistogram typing method. J Hosp Infect 1986;7:13–20.
144. Vaudry WL, Tierney AJ, Wenman WM. Investigation of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis 1988;158:1375–1379.
145. Burnie JP Odds FC, Lee W, Webster C, Williams JD. Outbreak of systemic Candida albicans in an intensive care unit caused by cross infection. Br Med J [Clin Res Ed] 1985;290:746–748.
146. Finkelstein R, Reinhertz G, Hashman N, Merzbach D. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1993;14:587–590.
147. Lee W, Burnie JP, Matthews RC, Oppenheim BO, Damani NN. Hospital outbreaks with yeasts. J Hosp Infect 1991;18(suppl A):237–249.
148. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH. Single source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989;27:2426–2428.
149. Hunter PR, Harrison GA, Fraser CA. Cross infection and diversity of Candida albicans strain carriage in patients and nursing staff on an intensive care unit. J Med Vet Mycol 1990;28:317–325.
150. Burnie JP Candida and hands. J Hosp Infect 1986;8:1–4.
151. Doebbeling BN, Hollis RJ, Isenberg HD, Wenzel RP, Pfaller MA. Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections. J Clin Microbiol 1991;29:1268–1270.
152. Burnie JP, Lee W, William JD, Matthews RC, Odds FC. Control of an outbreak of systemic Candida albicans. Br Med J [Clin Res Ed] 1985;291:1092–1093.
153. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. Am J Med 1976;60:471–485.
154. Centers for Disease Control. Nosocomial bacteremia associated with intravenous fluid therapy. MMWR 1971;20(suppl 9):81–82.
155. Snydman DR, Pober BR, Murray SA, Gorbea HF, Majka JA, Perry LK. Predictive value of surveillance skin cultures in total parenteral nutrition-related infection. Prospective epidemiologic study using semiquantitative cultures. Lancet 1982:1385–1388.
156. Kelsey MC, Gosling M. A comparison of the morbidity associated with occlusive and non-occlusive dressings applied to peripheral intravenous devices. J Hosp Infect 1984;5:313–321.
157. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982;92:720–727.
158. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct gram staining of catheter segments. N Engl J Med 1985;312:1142–1147.
159. deCicco M, Chiaradia V, Veronesi A, et al. Source and route of microbial colonization of parenteral nutrition catheters. Lancet 1989;2:1258–1261.
160. Capell S, Linares J, Sitges-Serra A. Catheter sepsis due to coagulase-negative staphylococci in patients on total parenteral nutrition. Eur J Clin Microbiol Infect Dis 1986;5:40–42.
161. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993;167:487–490.
162. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982;146:479–482.
163. Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985;21:357–360.
164. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. J Parenter Enteral Nutr 1985;9:322–325.
165. Raad I, Costerton W, Sabharwal U, et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400–407.
166. Pettigrew RA, Lang SDR, Haydock DA, Parry BR, Bremner DA, Hill GL. Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br J Surg 1985;72:52–55.
167. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Appl Microbiol 1974;28:778–784.
168. Sheth NK, Rose HD, Franson TR, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon catheters in hospitalized patients. J Clin Microbiol 1983;18:1061–1063.
169. Hogt AH, Dankert J, Feijen J. Encapsulation, slime production, and surface hydrophobicity of coagulase-negative staphylococci. FEMS Microbiol Lett 1983;18:211–215.
170. Ashkenazi S, Weiss E, Drucker MM. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity. J Lab Clin Med 1986;107:136–140.
171. Peters G, Locci R, Pulverer G. Microbial colonization of prosthetic devices, II: scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol 1981;173:293–299.
172. Locci R, Peters G, Pulverer G. Microbial colonization of prosthetic devices, I: microtopographical characteristics of intravenous catheters as detected by scanning microscopy. Zentralbl Bakteriol 1981;173:285–292.
173. Stillman RM, Soliman F, Garcia L, et al. Etiology of catheter-associated sepsis: correlation with thrombogenicity. Arch Surg 1977;112:1497–1502.
174. Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fib-rinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158:693–701.
175. Vaudaux P, Suzuki R, Waldvogel FA, Morgenthaler JJ, Nydegger UE. Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 1984;150:546–553.
176. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588–1595.
177. Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun 1986;54:13–20.
178. Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1984;1:365–367.
179. Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of gly-copeptide antibiotics. J Infect Dis 1990;161:37–40.
180. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation in slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994;32:452–456.
181. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
182. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977;296:1305–1309.
183. Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol 1988;26:175–177.
184. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1987;141:781–786.
185. Sherer tz RJ, Raad II, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76–82.
186. Raad II, Sabbagh MF, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1992;15:13–20.
187. Fan ST, Teoh-Chan CH, Lau KF. Evaluation of central venous catheter sepsis by differential quantitative culture. Eur J Clin Microbiol Infect Dis 1989;8:142–144.
188. Armstrong CW, Mayhall CG, Miller KB, et al. Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol 1990;11:71–78.
189. Wing EJ, Norden CW, Shadduck RK, Winkelstein A. Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med 1979;139:482–483.
190. Raucher HS, Hyatt AC, Barzilai A, et al. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr 1984;104:29–33.
191. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987;6:729–734.
192. Ruderman JW, Morgan MA, Klein AH. Quantitative cultures in the diagnosis of sepsis in infants with umbilical Broviac catheters. J Pediatr 1988;112:748–751.
193. Bansmer G, Keith D, Tesluk H. Complications following use of indwelling catheters of inferior vena cava. JAMA 1958;167:1606–1611.
194. Phillips RW, Eyre JD. Septic thrombophlebitis with septicemia. N Engl J Med 1958;259:729–731.
195. Indar R. The dangers of indwelling polyethylene cannulae in deep veins. Lancet 1959;1:284–286.
196. McNair TJ, Dudley HA. The local complications of intravenous therapy. Lancet 1959;2:365–368.
197. Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med 1960;262:947–951.
198. Horowitz HW, Dworkin BM, Savino JA, Byrne DW, Pecora NA. Central catheter-related infections: comparison of pulmonary artery catheters and triple lumen catheters for the delivery of hyperalimentation in a critical care setting. J Parenter Enteral Nutr 1990;14:558–592.
199. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987;258:2396–2403.
200. Maki DG, Goldmann DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867–887.
201. Collins RN, Braun PA, Zinner SH, Kass EH. Risk of local and systemic infection with polyurethane intravenous catheters. A prospective study of 213 catheterizations. N Engl J Med 1968;279:340–343.
202. Band JD, Maki DG. Steel needles used for intravenous therapy. Morbidity in patients with hematologic malignancy. Arch Intern Med 1980;140:31–34.
203. Tully JL, Friedland GH, Baldini LM, Goldman DA. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med 1981;70:702–706.
204. Mitchell A, Atkins S, Royle GT, Kettlewell MG. Reduced catheter sepsis and prolonged catheter life using a tunneled silicone rubber catheter for total parenteral nutrition. Br J Surg 1982;69:420–422.
205. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.
206. Maki DG. Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994;15:227–230.
207. Miller JJ, Venus B, Mathru M. Comparison of the sterility of long-term central venous catheterization using single-lumen, triple-lumen, and pulmonary artery catheters. Crit Care Med 1984;12:634–637.
208. Ullman RF, Gurevich I, Schoch PE, Cunha BA. Colonization and bacteremia related to duration of triple-lumen intravascular catheter placement. Am J Infect Control 1990;18:201–207.
209. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary artery catheters. N Engl J Med 1992;327:1062–1068.
210. Michel LA, Bradpiece HA, Randour P, Pouthier F. Safety of central venous catheter change over a guidewire for suspected catheter-related sepsis: a prospective randomized trial. Int Surg 1988;73:180–186.
211. Newsome HH Jr., Armstrong CW, Mayhall CG, et al. Mechanical complications from insertion of subclavian venous feeding catheters: comparison of de novo percutaneous venipuncture to change of catheter over guidewire. J Parenter Enteral Nutr 1984;8:560–562.
212. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three different methods of long-term catheter maintenance. Crit Care Med 1990;18:1073–1079.
213. Snyder RH, Archer FJ, Endy T, et al. Catheter infection. A comparison of two catheter maintenance techniques. Ann Surg 1988;208:651–653.
214. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72-hour intervals. Infect Control 1987;8:113–116.
215. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367–370.
216. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987;258:1777–1781.
217. Melley MA, Meng HC, Schaffner W. Microbial growth in lipid emulsions used in parenteral nutrition. Arch Surg 1975;110:1479–1481.
218. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol 1984;19:17–20.
219. Crocker KS, Noga R, Filibeck DJ, et al. Microbial growth comparisons of five commercial parenteral lipid emulsions. J Parenter Enteral Nutr 1984;8:391–395.
220. Keammerer D, Mayhall CG, Hall GO, Pesko LJ, Thomas RB. Microbial growth patterns in intravenous fat emulsions. Am J Hosp Pharm 1983;40:1650–1653.
221. McArthur BJ, Hargiss C, Schoenknecht FD. Stopcock contamination in an ICU. Am J Nurs 1975;75:96–97.
222. Walrath JM, Abbott NK, Caplan E, Scalan E. Stopcock: bacterial contamination in invasive monitoring systems. Heart Lung 1979;8:100–104.
223. Inoue Y, Nezu R, Matsuda H, et al. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. J Parenter Enteral Nutr 1992;16:581–585.
224. Crow S, Conrad SA, Chaney-Rowell C, King JW. Microbial contamination of arterial infusions used for hemodynamic monitoring: a randomized trial of contamination with sampling through conventional stopcocks versus a novel closed system. Infect Control Hosp Epidemiol 1989;10:557–561.
225. Gorbea HF, Snydman DR, Delaney A, Stockman J, Martin WJ. Intravenous tubing with burettes can be safely changed at 48hour intervals. JAMA 1984;251:2112–2115.
226. Maki DG. Sepsis arising from extrinsic contamination of the infusion and measures for control. In: Phillips I, Meers PD, D'Arcy PF, eds. Microbiological Hazards of Infusion Therapy. Lancaster, England: MTP Press; 1976:99–143.
227. Ayliffe GA, Babb JR, Davies JG, Lilly HA. Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 1988;11:226–243.
228. Rotter M, Koller W, Wewalka G. Povidone-iodine and chlorhexidine gluconate-containing detergents for disinfection of hands. J Hosp Infect 1980;1:149–158.
229. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–343.
230. Shapiro JM, Bond EL, Garman JK. Use of a chlorhexidine dressing to reduce microbial colonization of epidural catheters. Anesthesiology 1990;73:625–631.
231. Strand CL, Wajsbort RR, Sturmann K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA 1993;269:1004–1006.
232. Moran JM, Atwood RP, Rowe MI. A clinical and bacteriologic study of infections associated with venous cutdowns. N Engl J Med 1965;272:554–560.
233. Norden CW. Application of antibiotic ointment to the site of venous catheterization-a controlled trial. J Infect Dis 1969;120:611–615.
234. Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with indwelling intravenous catheters: effect of application of antibiotic ointment. J Infect Dis 1969;120:616–619.
235. Jarrad MM, Freeman JB. The effects of antibiotic ointments and antiseptics on the skin flora beneath subclavian catheter dressings during intravenous hyperalimentation. J Surg Res 1977;22:520–526.
236. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointment in prevention of vascular catheter-related infection. Am J Med 1981;70:739–744.
237. Flowers RH III, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989;261:878–883.
238. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101–106.
239. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae-a randomized controlled trial. J Hosp Infect 1990;15:311–321.
240. Smith MD, Sanghrijka M, Lock S. Mupirocin-resistant Staphylococcus aureus. Lancet 1987;2:1471–1473.
241. Smith GE, Kennedy CT. Staphylococcus aureus resistant to mupirocin. J Antimicrob Chemother 1988;21:141–142.
242. Noble WC, Rahman M, Cookson B, Phillips I. Transferable mupirocin-resistance. J Antimicrob Chemother 1988;22:771–772.
243. Katich M, Band J. Local infection of the intravenous-cannulae wound associated with transparent dressings. J Infect Dis 1985;151:971–972.
244. Dickerson N, Horton P, Smith S, Rose RC III. Clinically significant central venous catheter infections in a community hospital: association with type of dressing. J Infect Dis 1989;160:720–721.
245. Powell C, Regan C, Fabri PJ, Ruberg RL. Evaluation of Op-Site catheter dressings for parenteral nutrition: a prospective, randomized study. J Parenter Enteral Nutr 1982;6:43–46.
246. Ricard P, Martin R, Marcoux JA. Protection of indwelling vascular catheters: incidence of bacterial contamination and catheter-related sepsis. Crit Care Med 1985;13:541–543.
247. Young GP, Alexeyeff M, Russell DM, Thomas RJ. Catheter sepsis during parenteral nutrition: the safety of long-term Op- Site dressings. J Parenter Enteral Nutr 1988;12:365–370.
248. Maki DG, Stolz S, Wheeler S. A prospective, randomized, three-way clinical comparison of a novel, highly-permeable polyurethane dressing with 206 Swan Ganz pulmonary artery catheters: Op-Site IV 3000 vs Tegaderm vs gauze and Tape, I: cutaneous colonization under the dressing, catheter-related infection. In: Maki DG, ed. Improving Catheter Site Care. London, England: Royal Society of Medicine Services; 1991.
249. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing: a meta- analysis of the infection risks. JAMA 1992;267:2072–2076.
250. Quinlan A. In vivo assessment of microbial proliferation under Op-Site IV 3000, Tegaderm and Tegaderm Plus, with and without serum. In: Proceedings and Abstracts of the 3rd International Meeting of the Hospital Infection Society. London, England: Hospital Infection Society.
251. Babycos CR, Barracos A, Mancuso J, Turner-Marse T. Collodion as a safe, cost-effective dressing for central venous catheters. South Med J 1990;83:1286–1288.
252. Rusho WJ, Batt JN. Effect of filtration on complications of postoperative intravenous therapy. Am J Hosp Pharm 1979;36:1355–1356.
253. Allcutt DA, Lort D, McCollum CN. Final inline filtration for intravenous infusions: a prospective hospital study. Br J Surg 1983;70:111–113.
254. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis. Its prevention by in-line filtration. N Engl J Med 1985;312:78–82.
255. Maddox RR, John JF Jr, Brown LL, Smith CE. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983;2:58–61.
256. Turco SJ, Davis NM. Particulate matter in intravenous infusion fluids-phase 3. Am J Hosp Pharm 1973;30:611–613.
257. Baumgartner TG, Schmidt GL, Thakker KM, et al. Bacterial endotoxin retention by inline intravenous filters. Am J Hosp Pharm 1986;43:681–684.
258. Butler DL, Munson JM, Deluca PP. Effect of inline filtration on the potency of low-dose drugs. Am J Hosp Pharm 1980;37:935–941.
259. Freeman JB, Litton AA. Preponderance of gram-positive infections during parenteral alimentation. Surg Gynecol Obstet 1974;139:905–908.
260. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988;85:307–314.
261. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of the silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993;218:206–210.
262. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985;97:547–551.
263. Bach A. Bohrer H, Motsch J, Martin E, Geiss HK, Sonntag HG. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. J Antimicrob Chemother 1994;33:969–978.
264. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418–424.
265. Sherertz RJ, Forman DM, Soloman DD. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 1989;33:1174–1178.
266. Greenfeld JI, Sampath L, Popilskis SJ, Brunnert Sr, Stylianos S, Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit Care Med 1995;23:894–900.
267. Sherertz RJ, Carruth A, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993;167:98–106.
268. Carruth WA, Byron MP, Solomon DD, et al. Subcutaneous, catheter-related inflammation in a rabbit model correlates with peripheral vein phlebitis in human volunteers. J Biomed Mater Res 1994;28:259–267.
269. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991;265:2364–2368.
270. Nelson DB, Kien CL, Mohr B, Frank S, Davis SD. Dressing changes by specialized personnel reduce infection rates in patients receiving central venous parenteral nutrition. J Parenter Enteral Nutr 1986;10:220–222.
271. Faubion WC, Wesley JR, Khaldi N, Silva J. Total parenteral nutrition catheter sepsis: impact of the team approach. J Parenter Enteral Nutr 1986;10:642–645.
272. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective control study. Arch Intern Med 1984;144:1191–1194.
273. Bock SN, Lee RE, Fisher B, et al. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 1990;8:161–169.
274. Al-Sibai MB. The value of prophylactic antibiotics during insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer 1987;60:1891–1895.
275. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15:95–102.
276. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985;6:419–425.
277. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-nega-tive staphylococcal sepsis in neonates. J Pediatr 1994;125:259–263.
278. Kacica MA, Horgan MJ, Ochoa L, Sander R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994;125:253–258.
279. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990;8:1591–1597.
280. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271(13):1014–1016.
281. Ashton J, Gibson V, Summers S. Effects of heparin versus saline solution on intermittent infusion device irrigation. Heart Lung 1990;19:608–612.
282. Weber DR. Is heparin really necessary in the lock and, if so, how much? Drugs Intelligence and Clinical Pharmacy Annals of Pharmacotherapy 1991;25:399–407.
283. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 1988;32:1627–1631.
284. Passannate A, Macik BG. Case report: the heparin flush syndrome: a cause of iatrogenic hemorrhage. Am J Med Sci 1988;296:71–73.
285. Heeger PS, Backstrom JT. Heparin flushes and thrombocy-topenia. Ann Intern Med 1986;105:143. Letter.
286. Rhodes GR, Dixon RH, Silver D. Heparin induced thrombocy-topenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 1973;136:406–416.
287. Garrelts JC. White clot syndrome and thrombocytopenia: reasons to abandon heparin IV lock flush solution. Clin Pharm 1992;11:797–799.
288. Silver D, Kapsch DN, Tsoi EK. Heparin-induced thrombocy-topenia, thrombosis, and hemorrhage. Ann Surg 1983;198:301–306.
289. Sketch MH, Cale M, Mohiuddin SM, Booth RW. Use of percutaneously inserted venous catheters in coronary care units. Chest 1972;62:684–689.
290. Bassan MM, Sheikh-Hamad D. Prevention of lidocaine-infu-sion phlebitis by heparin and hydrocortisone. Chest 1983;84:439–441.
291. Daniell HW. Heparin in the prevention of infusion phlebitis. A double-blind controlled study. JAMA 1973;226:1317–1321.
292. Makarewicz PA, Freeman JB, Fairfull-Smith R. Prevention of superficial phlebitis during parenteral nutrition. Am J Surg 1986;151:126–129.
293. Wright A, Hecker JF, Lewis GB. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusion due to phlebitis and extravasation. Lancet 1985;2:1148–1150.
294. Khawaja HT, Campbell MS, Weaver PC. Effect of transdermal glyceryl trinitrate on the survival of peripheral intravenous infusions: a double-blind prospective clinical study. Br J Surg 1988;75:1212–1215.
295. Woodhouse CR. Movelat in the prevention of infusion thrombophlebitis. Br Med J 1979;1:454–455.
296. O'Brien BJ, Buxton MJ, Khawaja HT. An economic evaluation of transdermal glycerly trinitrate in the prevention of intravenous infusion failure. J Clin Epidemiol 1990;43:757–763.
297. Adams KS, Zehrer CL, Thomas W. Comparison of a needleless system with conventional heparin locks. Am J Infect Control 1993;21:263–269.
298. Danzig LE, Short L, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system and total parenteral nutrition. JAMA 1995;273:1862–1864.
299. Larson EL, Cheng G, Choo JTE, Merz W. In vitro survival of skin flora in heparin locks and needleless valve infusion devices. Heart Lung 1993;22:459–462.
300. Longfield R, Longfield J, Smith LP, Hyams KC, Strohmer ME. Multidose medication vial sterility: an in-use study and a review of the literature. Am J Infect Control 1984;5:165–169.
301. Kothari T, Reyes MP, Brooks N, Brown MJ, Lerner AM. Pseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone. Can Med Assoc J 1977;116:1230–1235. Letter.
302. Nakashima AK, Highsmith AK, Martone WJ. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis. J Clin Microbiol 1987;25:1019–1021.
303. Alter MJ, Ahtone J, Maynard JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330–333.
304. Highsmith AK, Greenhood R, Allen JR. Growth of nosocomial pathogens in multiple-dose parenteral medication vials. J Clin Microbiol 1982;15:1024–1028.
305. Lehmann CR. Effect of refrigeration on bactericidal activity of four multiple-dose injectable drug products. Am J Hosp Pharm 1977;34:1196–1200.
306. Llop JM, Mangues I, Perez JL, Lopez P, Tubau M. Staphylococcus saprophyticus sepsis related to total parenteral nutrition admixtures contamination. J Parenter Enteral Nutr 1993;17:575–577.
307. Degleux G, Le Coutour X, Hecquard C, Oblin I. Septicemia caused by contaminated parenteral nutrition pouches: the refrigerator as an unusual cause. J Parenter Enteral Nutr 1991;15:474–475.
308. Scheckelhoff DJ, Mirtallo JM, Ayers LW, Visconti JA. Growth of bacteria and fungi in total parenteral nutrient admixtures. Am J Hosp Pharm 1986;43:73–77.
309. Goldmann DA, Martin WT, Worthington JW. Growth of bacteria and fungi in total parenteral nutrition solutions. Am J Surg 1973;126:314–318.
310. D'Angio RG, Riechers KC, Gilsforf RB, Constantino JM. Effect of the mode of lipid administration on parenteral nutrition-related infections. Ann Pharmacother 1992;26:14–17.
311. Vasilakis A, Apelgren KN. Answering the fat emulsion question: three in one admixture vs conventional total parenteral nutrition in a clinical setting. J Parenter Enteral Nutr 1988;12:356–359.
312. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections. Am J Med 1982;73:695–699.
313. Ryan JA Jr., Abel RM, Abbott WA, et al. Catheter complication in parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974;290:757–761.
314. Vanhuynegem L, Parmentier P, Potvliege C. In situ bacteriologic diagnosis of total parenteral catheter infection. Surgery 1988;103:174–177.
315. Keohane PP, Jones B, Attrill H, et al. Effect of catheter tunneling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet 1983;2:1388–1390.
316. Powell CR, Traetow MJ, Fabri PJ, Kudsk KA, Ruberg RL. Op-Site dressing study: a prospective randomized study evaluating povidone iodine ointment and extension set changes with 7-day Op-Site dressings applied to total parenteral nutrition subclavian sites. J Parenter Enteral Nutr 1985;9:443–446.
317. Herruzo-Cabrera R, Garcia-Cabellero J, Vera-Cortes L, et al. Growth of microorganism in parenteral nutrient solutions. Am J Hosp Pharm 1984;41:1178–1180.
318. Federal Standard No. 209E. Airborne particulates cleanliness classes in clean rooms and clean zones. Washington, DC: General Services Administration; 1992.
319. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm 1993;50:2386–2398.
320. Rannem T, Ladefoged K, Hegnhoj F, Hylander Moller E, Bruun B, Farnum S. Catheter-related sepsis in long-term parenteral nutrition with Broviac catheters. An evaluation of different disinfectants. Clinical Nutrition 1990;9:131–136.
321. Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is no value as an infection control measure. Controlled clinical trial. Am J Med 1987;83:833–840.
322. Palidar PJ, Simonowitz DA, Oreskovich MR, et al. Use of Op-Site as an occlusive dressing for total parenteral nutrition catheters. J Parenter Enteral Nutr 1982;6:150–151.
323. Uldall PR, Dyck RF, Woods F, et al. A subclavian catheter for temporary vascular access for hemodialysis and plasmapheresis. Dialysis Transplant 1979;296:1305–1309.
324. Tokars JI, Alter MS, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated disease in the United States, 1990. ASAIO J 1993;39:71–80.
325. Keane WF, Shapiro FL, Raij L. Incidence and type of infection occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs 1977;23:41–47.
326. Pezzarossi HE, Ponce de Leon S, Calva JJ, Lazo de la Vega SA, Ruiz-Palacios GM. High incidence of subclavian dialysis catheter-related bacteremias. Infect Control 1986;7:596–599.
327. Kong NC, Morad Z, Suleiman AB. Subclavian catheters as temporary vascular access. Singapore Med J 1989:261–262.
328. Shaffer D, Madras PN, Williams ME, D'Elia JA, Kaldany A, Monaco AP. Use of Dacron cuffed silicone catheters as long-term hemodialysis access. ASAIO J 1992:55–58.
329. Shusterman NH, Kloss K, Mullen JL. Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access. Kidney Int 1989;35:887–890.
330. Bour ES, Weaver AS, Yang HC, Gifford RR. Experience with the double-lumen silastic catheter for hemoaccess. Gynecol Obstet 1990;171:33–39.
331. Almirall J, Gonzalez J, Rello J, et al. Infection of hemodialysis catheters: incidence and mechanisms. Am J Nephrol 1989;1989:454–459.
332. Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 1986;154:579–589.
333. Sherertz RJ, Falk RJ, Huffman KA, Thomann CA, Mattern WD. Infections associated with subclavian Uldall catheters. Arch Intern Med 1983;143:52–56.
334. Blake PG, Huraib S, Uldall PR. The use of dual lumen jugular venous catheters as definitive long term access for haemodialysis. Int J Artif Organs 1990;13:26–31.
335. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients on chronic hemodialysis. Ann Intern Med 1978;88:28–33.
336. Vanherweghem JL, Dhaene M, Goldman M, et al. Infections associated with subclavian dialysis catheters: the key role of nurse training. Nephron 1986;42:116–119.
337. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney 1990;16:211–215.
338. Watson AR, Bahoric A, Wesson D. A central venous (W-B-W) catheter for multipurpose vascular access in children. Artif Organs 1986;10:59–61.
339. Canaud B, Beraud JJ, Joyeux H, Mion C. Internal jugular vein cannulation using two silastic catheters. A new simple, safe long-term vascular access for extracorporeal treatment. Nephron 1986;43:133–138.
340. Donnelly PK, Hoenich NA, Lennard TW, Proud G, Taylor RM. Surgical management of long-term central venous access in uraemic patients. Nephrol Dial Transplant 1988;3:57–65.
341. Tapson JS, Uldall PR. Avoiding deaths from subclavian cannulation for haemodialysis. Int J Artif Organs 1983;6:227–230.
342. Barton BR, Hermann G, Weil R III. Cardiothoracic emergencies associated with subclavian hemodialysis catheters. JAMA 1983;250:2600–2662.
343. Tapson JS, Uldall R. Fatal hemothorax caused by a subclavian hemodialysis catheter. Thoughts on prevention. Arch Intern Med 1984;144:1685–1687.
344. Brady HR, Fitzcharles B, Goldberg H, et al. Diagnosis and management of subclavian vein thrombosis occurring with subclavian cannulation for hemodialysis. Blood Purif 1989;7:210–217.
345. Schwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL. Prospective evaluation of a Dacron-cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988;11:166–169.
346. Pourchez T, Moriniere P, Fournier A, Pietri J. Use of a Perm-cath (Quinton) catheter in uraemic patients in whom the creation of conventional vascular access for haemodialysis is difficult. Nephron 1989;53:297–302.
347. Foissac-Gegoux P, Dumont A. Septicemias au cours du traite-ment par hemodialyse periodique. Nouv Presse Med 1974;3:151.
348. Meyrier A, Chevet D, Marsac J, Leroux-Robert C, Sraer JD, Scetbon V. Staphylococcemias chez las malades hemodialyses. Nouv Presse Med 1973;2:2379–2383.
349. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HD, Mayhall CG. A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 1988;9:534–541.
350. Cappello M, De Pauw L, Bastin G, et al. Central venous access for hemodialysis using the Hickman catheter. Nephrol Dial Transplant 1989;4:988–992.
351. Vanherweghem JL, Cabolet P, Dhaene M, et al. Complications related to subclavian catheters for hemodialysis. Int J Artif Organs 1986;5:297–309.
352. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91–96.
353. Kirmani S, Tuazon CU, Murray HW, Parrish AE, Sheagran JN. Staphylococcal aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978;138:1657–1679.
354. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991;40:934–938.
355. Ralston AJ, Harlow GR, Jones DM, Davis P. Infections of Scribner and Brescia arteriovenous shunts. Br Med J 1971;3:408–409.
356. Goldblum SE, Ulrich JA, Goldman RS, Reed WP. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of staphylococcal carriage. Am J Kidney Dis 1982;2:281–286.
357. Uldall PR. Subclavian cannulation for hemodialysis. Int J Artif Organs 1981;4:213–214.
358. Carlisle EJ, Blake P, McCarthy F, Vas S, Uldall R. Septicemia in long-term jugular hemodialysis catheters: eradicating infection by changing the catheter over a guidewire. Int J Artif Organs 1991;14:150–153.
359. Graeve AH, Carpenter CM, Schiller WR. Management of central venous catheters using a wire introducer. Am J Surg 1981;142:752–755.
360. Farber BF. The multi-lumen catheter: proposed guidelines for its use. Infect Control Hosp Epidemiol 1988;9:206–208.
361. Domoto DT, Kennedy DJ. Antibiotic treatment of chronic central venous hemodialysis catheter infection without catheter removal. Int J Artif Organs 1985:239–240.
362. Garland JS, Dunne WM, Havens P, et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992;89:1145–1150.
363. Freeman J, Platt R, Sidebottom DG, Leclair JM, Epstein MF, Goldmann DA. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA 1987;258:2548–2552.
364. Garland JS, Nelson DB, Cheah T, Hennes HH, Johnson TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J 1987;6:918–921.
365. Batton DG, Maisels MJ, Appelbaum P. Use of peripheral intravenous cannulas in premature infants: a controlled study. Pediatrics 1982;70:487–490.
366. Furfaro S, Gauthier M, Lacroix J, Nadeau D, Lefleur L, Mathews S. Arterial catheter-related infections in children: a 1-year cohort analysis. Am J Dis Child 1991;145:1037–1043.
367. Adam RD, Edwards LD, Becker CC, Schrom HM. Semiquantitative cultures and routine tip cultures on umbilical catheters. J Pediatr 1982;100:123–126.
368. Danker WM, Spector SA, Fierer J, Davis CE. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis 1987;9:743–753.
369. Garcia CR, Johnston BL, Corvi G, Walker LJ, George WL. Intravenous catheter-associated Malassezia furfur fungemia. Am J Med 1987;83:790–792.
370. Long JG, Keyserling HL. Catheter-related infection in infants due to an unusual lipophilic yeast-Malassezia furfur. Pediatrics 1985;76:896–900.
371. Alpert G, Bell LM, Campos JM. Malassezia furfur fungemia in infancy. Clin Pediatr 1987;26:528–531.
372. Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994;15:315–318.
373. Gaynes RP, Martone WJ, Culver DH, et al. Comparison of rates of nosocomial infections in neonatal intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991;91(suppl 3B):192S-196S.
374. Cronin WA, Germanson TP, Donowitz LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol 1990;11:301–308.
375. Nelson DB, Garland JS. The natural history of Teflon catheter associated phlebitis in children. Am J Dis Child 1987;141:1090–1092.
376. Garland JS, Buck RK, Maloney P et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14:510–516.
377. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991;145:675–680.
378. Krauss AN, Albert RF, Kannan MM. Contamination of umbilical catheters in the newborn infant. J Pediatr 1970;77:965–969.
379. Balagtas RC, Bell CE, Edwards LD, Levin S. Risk of local and systemic infections associated with umbilical vein catheterization: a prospective study in 86 newborn patients. Pediatrics 1971;48:359–367.
380. Bard H, Albert G, Teasdale F, Doray B, Martineau B. Prophylactic antibiotics in chronic umbilical artery catheterization in respiratory distress syndrome. Arch Dis Child 1973;48:630–635.
381. Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases, XII. Boston, MA: Blackwell Scientific Publications; 1992:83–110.
382. LaQuaglia MP, Lucas A, Thaler HT, Friedlander-Klar H, Exelby PR, Groeger JS. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992;27:840–842.
383. Wiener ES, McGuire P, Stolar CJ, et al. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg 1992;27:155–164.
384. Sola JE, Stone MM, Wise B, Columbani PM. Atypical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis. Pediatr Pulmonol 1992;14:239–242.
385. Johnson PR, Decker MD, Edwards KM, et al. Frequency of Broviac catheter infections in pediatric oncology patients. J Infect Dis 1984;154:570–578.
386. Mulloy RH, Jadavji T, Russell ML. Tunneled central venous catheter sepsis: risk factors in a pediatric hospital. J Parenter Enteral Nutr 1991;15:460–463.
387. Gorelick MH, Owen WC, Seibel NL, Reaman GH. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 1991;10:506–510.
388. Mirro JJ, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214–222.
389. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complications. Crit Care Med 1989;17:984–988.
390. East SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. J Intraven Nurs 1994;17:189–192.
391. Food and Drug Administration, Center for Devices and Radiological Health, Office of Technical Assistance, Central Venous Catheter Working Group. Central venous catheter complications (a three part series); Winter 1994.
392. Kyle KS, Myers JS. Peripherally inserted central catheters. Development of a hospital-based program. J Intraven Nurs 1990;13:287–290.
393. BeVier PA, Rice CE. Initiating a pediatric peripherally inserted central catheter and midline catheter program. J Intraven Nurs 1994;17:201–205.
394. Conly JM, Hill S, Ross J, Lertzman J, Louie T.J., Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Clin Pathol 1989;17:330–339.
395. Seto WH, Ching TY, Yuen KY, Chu YB, Seto WL. The enhancement of infection control in-service education by ward opinion leaders. Am J Clin Pathol 1991;19:86–91.
396. Freeman J, McGowan JE Jr. Methodologic issues in hospital epidemiology, I: rates, case finding, and interpretation. Rev Infect Dis 1981;3:658–667.
397. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.
398. Josephson A, Karanfil L, Alonso H, Watson A, Bilght J. Risk-specific nosocomial infection rates. Am J Med 1991;91(suppl 3B):131S-137S.
399. Evans ME, Schaffner W, Federspiel CF, Cotoon RB, McKee KT, Stratton CW. Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. JAMA 1988;259:248–252.
400. Raad I, Baba M, Bodey GP. Diagnosis of catheter-related infections: role of the surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995;20:593–597.
401. Adams BG, Marrie TJ. Hand carriage of gram-negative rods may not be transient. J Hyg 1982;89:33–46.
402. Adams BG, Marrie TJ. Hand carriage of gram-negative rods by health care personnel. J Hyg 1982;89:23–31.
403. Steere AC, Mallison GF. Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975;1975:83.
404. Casewell M, Phillips I. Hands as a route of transmission of Klebsiella species. Br Med J 1977;2:1315–1317.
405. Sprunt K, Redman W, Leidy G. Antimicrobial effectiveness of routine handwashing. Pediatrics 1973;52:264–271.
406. Daschner FD. The transmission of infections in hospitals by staff carriers, methods of prevention and control. Infect Control 1985;6:97–98.
407. Simmons B, Bryant J, Neiman K, et al. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol 1990;11:589–594.
408. Reybrouck G. Role of the hands in the spread of nosocomial infections. J Hosp Infect 1983;41:103–110.
409. Knittle MA, Eitzman DV, Baer H. Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infections. J Pediatr 1975;86:433–437.
410. Centers for Disease Control and Prevention. Update: universal precautions for prevention of transmission of HIV, Hepatitis B, and other bloodborne pathogens in healthcare settings. MMWR 1988;24:377–382, 387–388.
411. McKee KT Jr., Melly MA, Greene HL, Schaffner W. Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. Am J Dis Child 1979;133:649–650.
412. Allen JR. Guidelines for changing administration sets for intravenous therapy. National Intravenous Therapy Association. 1980;3:175–179.
413. Ansel HC, Gigandet MP. Change in pH of infusion solutions upon mixing with blood. JAMA 1971;218:1052.
414. Leroy O, Billau V, Beuscart C, et al. Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Med 1989;15:241–256.
415. Ruschman KL, Fulton JS. Effectiveness of disinfectant techniques on intravenous tubing latex injection ports. J Intraven Nurs 1993;16:304–308.
416. Cortopassi RF, Kikugawa CA. Evaluation of antiseptics in the preparation of intravenous admixtures. Am J Hosp Pharm 1977;34:1193–1196.
417. Plott RT, Wagner RF, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol 1990;126:1441–1444.
418. Shulan DJ, Weiler JM, Koontz F, Richerson HB. Contamination of intradermal skin test syringes. J Allergy Clin Immunol 1985;76:226–227.
419. Lutz CT, Bell CE Jr, Wedner HJ, Krogstad DJ. Allergy testing of multiple patients should no longer be performed with a common syringe. N Engl J Med 1984;310:1335–1337.
420. Scalley RD, Van CS, Cochran RS. The impact of an IV team on the occurrence of intravenous-related phlebitis. A 30-month study. J Intraven Nurs 1992;15:100–109.
421. Thomson S. IV therapy: a financial feasibility study. Nurs Manage 1993;24:68A-68G.
422. Smith I, Hathaway M, Goldman C, et al. A randomized study to determine complications associated with duration of insertion of heparin locks. Res Nurs Health 1990;13:367–373.
423. American Society of Hospital Pharmacists. ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices. Am J Hosp Pharm 1994;51:1572–1574.
424. Goode CJ, Titler M, Rakel B, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 1991;40:324–330.
425. Gyves J, Ensminger W, Niederhuber J, et al. Totally-implanted system for intravenous chemotherapy in patients with cancer. Am J Med 1982;73:841–845.
426. Nahata MC, King DR, Powell DA, Marx SM, Ginn-Pease ME. Management of catheter-related infections in pediatric patients. J Parenter Enteral Nutr 1988;12:58–59.
427. Powell C, Kudsk KA, Kulich PA, Mandelbaum JA, Fabri PJ. Effect of frequent guidewire changes on triple-lumen catheter sepsis. J Parenter Enteral Nutr 1988;12:462–464.
428. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectant to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31:475–479.
429. Wormser GP, Onorato IM, Preminger TJ, Culver D, Martone WJ. Sensitivity and specificity of blood cultures obtained through intravascular catheters. Crit Care Med 1990;18:152–156.
430. Bryant JK, Strand CL. Reliability of blood cultures collected from intravascular catheter versus venipuncture. Am J Clin Pathol 1987;88:113–116.
431. Felices FJ, Hernandez JL, Ruiz J, Meseguer J, Gomez JA, Molina E. Use of the central venous pressure catheter to obtain blood cultures. Crit Care Med 1979;7:78–79.
432. Tafuro P, Colbourn D, Gurevich I, et al. Comparison of blood cultures obtained simultaneously by venopuncture and from vascular lines. J Hosp Infect 1986;7:283–288.
433. Mayo DJ, Helsabeck CB, Horne DK III. Intraluminal clots in Groshong catheters. JVAD 1995;1:20–22.
434. Nehme AE, Trigger JA. Catheter dressings in central parenteral nutrition: a prospective randomized comparative study. Nutritional Support Services 1984;4:42.
435. White WJ, Hurst WJ, Achey BE, Lang CM. Effectiveness of skin absorption of tincture of I in blocking radioiodine from the human thyroid gland. Health Phys 1989;56:911–914.